Doctor’s Guide -- WASHINGTON, DC -- October 10, 2010 -- While recipients of ventricular-assist devices (VAD) are prone to developing heparin-induced thrombocytopenia (HIT), repeated exposure to heparin may lead to the development of HIT-resistance, researchers said here at the 96th Annual Clinical Congress of the American College of Surgeons (ACS).
